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Summary
Multiple sclerosis (MS) is a neurological, demyelinating
disorder with a putative autoimmune etiology. It is
thought to be a multifactorial disease with a complex
mode of inheritance. Here we report the results of a two-
stage genomewide scan for loci predisposing to MS. The
first stage of the screen, with a low-resolution map, was
performed in a selection of 16 pedigrees collected
from an isolated Finnish population. Multipoint, non-
parametric linkage analysis of the 328 markers did not
reveal statistically significant results. However, 10
slightly interesting regions ( ) emerged, in-P  .1–.15
cluding our previous findings of the HLA complex on
6p21 and a putative locus on 5p14-p12. Eight of these
novel regions were further analyzed by use of denser
marker maps, in the second stage of the scan. For the
chromosomal regions 4cen, 11tel, and 17q, the statistical
significance increased, but not conclusively; for 2q32
and 10q21, the statistical significance did not change.
Accordingly, genotyping of the high-density markers in
these regions was performed, and the data were analyzed
by use of two-point, parametric linkage analysis using
the complete pedigree information of the 21 Finnishmul-
tiplex families. We detected suggestive evidence for a
predisposing locus on chromosomal region 17q22-q24.
Several markers on 17q22-q24 yielded positive LOD
scores, with the maximum LOD score (Zmax) occurring
with D17S807 ( , ; dominant model).Z  2.8 v  .04max
Interestingly, a suggestive linkage between MS and the
markers on 17q22-q24 was also revealed by a recent
genomewide scan in MS families from the United
Kingdom.
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Introduction
Multiple sclerosis (MS) is an inflammatory, demyelin-
ating disease of the CNS. The prevalence of this putative
autoimmune disorder is 0.1% in Caucasians of northern
European origin. MS has an obvious genetic component,
as indicated by the higher concordance rate of
25%–30% in MZ twins and by the 20–40-times greater
risk in siblings compared with the general population
(Ebers et al. 1986; Sadovnick et al. 1988). Adoption and
half-sib studies show evidence for genetic determinants
but also implicate the importance of environmental fac-
tors in the etiology (Ebers et al. 1995; Sadovnick et al.
1996). The candidate-gene approach has not been very
encouraging: positive findings in one data set have usu-
ally not been replicated in other studies (Beall et al. 1989;
Seboun et al. 1989; Hillert et al. 1991; Lynch et al.
1991). Thus far, only association with the HLA complex
on 6p21 has been a well-established finding in most pop-
ulations (Olerup and Hillert 1991).
Recently, three publications reported the results of ge-
nomewide screens of MS in families collected from the
United Kingdom, Canada, and the United States, but no
major susceptibility locus could be detected (Ebers et al.
1996; TheMultiple Sclerosis Genetics Group 1996; Saw-
cer et al. 1996). Each study reported several provisional
sites, but only two such genomic regions, 6p21 (HLA
complex) and 5p, were positive in more than one data
set. Together, these genome screens support previous as-
sertions of a polygenic and heterogenic etiology of MS.
Nonetheless, the number and the character of genes pre-
disposing to MS remains unknown.
We have focused our genetic studies of MS on the
isolated Finnish population, which originates from a lim-
ited number of founders (de la Chapelle 1993). This
population structure should be highly useful in genetic
studies of a complex disease, because of the likely re-
stricted number of founder mutations. Using a candidate
gene approach, we have previously found evidence for
the contribution of three distinct chromosomal regions
to the genetic susceptibility of MS in 21 Finnish families:
1380 Am. J. Hum. Genet. 61:1379–1387, 1997
the region containing the Golli (for gene expressed in
the oligodendrocyte lineage)-MBP (formyelin basic pro-
tein) gene on 18q22-q23, the HLA complex on 6p21,
and a region on 5p14-p12 (Tienari et al. 1992b, 1993;
Kuokkanen et al. 1996).
Here we present the results of a genomewide scan
performed in the same Finnish multiplex MS families,
utilizing a semiautomated mapping technique. The study
was conducted in a two-stage approach, and statistical
analyses were performed by use of both multipoint, non-
parametric-linkage analysis and two-point, parametric-
linkage analysis. The results suggest evidence for linkage
on 17q22-q24—in exactly the same region that showed
suggestive linkage to MS in two British data sets (Sawcer
et al. 1996).
Families, Material, and Methods
Pedigrees and Affection Status
The complete study material consisted of 21 MS fam-
ilies with two to six affected cases per pedigree (fig. 1).
These families are identical to those previously used in
our genetic-mapping studies (Tienari et al. 1992b, 1993;
Kuokkanen et al. 1996). Fourteen of them originated
from the province of Vaasa in western Finland, where
the prevalence of MS is twice as high as elsewhere in
Finland and where the familial occurrence of MS is in-
creased as much as 30% (Wikstro¨m 1975; Kinnunen et
al. 1983). Diagnosis ofMS in affected individuals strictly
followed Poser’s diagnostic criteria (Poser et al. 1983).
In magnetic-resonance imagining (MRI), three asymp-
tomatic siblings showed lesions typical for MS, and their
affection status was regarded as unknown in the analysis
(Tienari et al. 1992a). Two patients with a diagnosis of
optic neuritis were members in the families withmultiple
MS cases originating from the high-risk region of Vaasa,
and thus, in the present study, we regarded these indi-
viduals as affected (Ebers et al. 1981).
A two-stage genomewide screen with increasing
marker resolution was performed on 104 individuals
from the 16 most informative families of the 21 families,
including 11 from the Vaasa region. For the screens, we
included all affected individuals of the 16 families, as
well as either their parents, if available, or two or three
unaffected siblings. With this selection, individuals to be
genotyped were chosen on the basis of either their af-
fection status or their ability to facilitate phase
determination.
For the final phase of the study, we selected chro-
mosomal regions in which addition of the denser set of
markers either led to an increase in statistical significance
or did not change it. In an effort to extract complete
pedigree information, we extended the number of fam-
ilies from 16 to 21, genotyped all 191 available indi-
viduals, and performed two-point linkage analysis. At
this stage, we included all individuals for the study, since
two-point linkage analysis using FASTLINK resulted in
the utilization of information from all individuals in the
pedigree; however, a parametric inheritance model
needed to be specified. In contrast, multipoint, nonpar-
ametric linkage analysis using GENEHUNTER resulted
in the utilization of information from all markers, but
some individuals of the larger pedigrees were excluded
because of computational constraints of the program.
Seven (44%) of the 16 pedigrees used in our scan were
sufficiently large to require trimming in this fashion, for
the GENEHUNTER multipoint analysis.
Low- and High-Resolution Maps
A low-resolution map of 328 polymorphic, fluores-
cently labeled markers from the Cooperative Human
Linkage Center (CHLC) human screening set/Weber ver-
sion 6.0 were used for the initial stage of our study. The
order and sex-averaged distance of the scan markers
were based on the published CHLC map (Murray et al.
1994; http://www.chlc.org/ChlcMaps.html/). Markers
had an average heterozygosity of .76 and an average
spacing of 12 cM.
For follow-up of the low-resolution genetic screen, we
selected those regions with a nonparametric linkage
(NPLall) score 11 (corresponding to ). This cri-P ≈ .16
terion is clearly well below the threshold for statistical
significance but provided a convenient cutoff for iden-
tification of regions meriting higher-density genotyping.
The high-density genotyping proceeded as follows: six
markers on chromosomal region 2q, six markers on 3q,
seven markers on 4cen, four markers on 10q, three
markers on 11tel, seven markers on 17q, three markers
on 18tel, and four markers on 19tel. Microsatellite
markers for the high-resolution screen were selected
from the CHLC and Ge´ne´thon marker maps (Murray
et al. 1994; Dib et al. 1996). The marker order and
distance were determined according to published inte-
grated maps (Genome Database andMarshfieldMedical
Research Foundation). The reported marker order was
consistent with the recombination data observed in the
Finnish MS families. The average marker spacing for the
fine-mapping regions was 4.5 cM (range 0.01–10 cM).
For 17q22-q24, we selected the same markers as were
used in the previously published British study, to aid in
a direct comparison of the results (Sawcer et al. 1996).
The marker order on 17q22-q24 was confirmed by use
of radiation hybrid mapping (Stanford version G3). Ac-
cording to the physical map of the 17q22-q24 region,
the positions of all other markers were in agreementwith
the published genetic maps, except for D17S1882, which
is located distal to D17S807 (Whitehead Institute/
MIT Genome Center [http://www-genome.wi.mit.edu/
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Figure 1 Pedigrees of 21 Finnish MS families. Families 1–7, 9, 11–15, and 21 originate from the Vaasa region, a high-risk region in
western Finland. Families 1–5, 9–12, 14–18, 20, and 21 were included in the initial stage of the genomewide scan. Three pedigrees, families
2, 5, and 16, have previously been published by our group (Tienari et al. 1992b).
cgi-bin/contig/physmap]). Here we used the marker or-
der based on the physical map.
Determination of the Haplotypes
For the low-resolution genome scan, we used fluores-
cently labeled markers, which were detected by use of
an ABI 377 sequencer (Perkin-Elmer). Gels were pro-
cessed by use of BASS/GRACE (L. D. Stein, unpublished
data; also see http://www-genome.wi.mit.edu/ftp/
distribution/software/); size standards and alleles were
determined automatically by use of in-home allele-call-
ing software (M. J. Daly, unpublished data), and gen-
otypes were stored in a LABBASE database (http://
www-genome.wi.mit.edu/ftp/distribution/software/).
Segregation was checked and linkage-formatted files
were produced by use of PEDMANAGER (M. P. Reeve-
Daly, personal communication). Markers for the high-
resolution mapping were genotyped by use of either the
aforementioned protocol or radioactively labeled mark-
ers as described elsewhere (Kuokkanen et al. 1996).
Statistical Analysis
Multipoint, nonparametric linkage analysis of the
low- and high-resolution genome screens was performed
by use of the GENEHUNTER computer package (Krug-
lyak et al. 1996). The analysis was performed on a panel
of 16 pedigrees and a subpanel of 11 Vaasa pedigrees,
in an attempt to enrich for possible genetic homogeneity.
To incorporate complete pedigree information in sta-
tistical analysis, we also used two-point linkage analysis
for the high-resolution mapping. Two-point linkage
analysis was performed by use of the MLINK program
of the LINKAGE package, FASTLINK version 2.2 (La-
throp et al. 1984; Cottingham et al. 1993; Scha¨ffer et
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al. 1994). Genetic heterogeneity was tested by use of the
admixture test of the HOMOG program (Ott 1991).
Since the mode of inheritance of MS is unknown, LOD-
score analysis was performed by use of four different
modes of inheritance: dominant and recessive, each with
reduced penetrance of either or . In thef  .05 f  .76
dominant model with penetrance value of either f 
or , we used disease allele–frequency esti-.05 f  .76
mates of and , respectively, as ex-P  .01 P  .0006
plained elsewhere (Kuokkanen et al. 1996); and in the
recessive model with penetrance value of either f 
or , we used disease allele–frequency esti-.05 f  .76
mates of and , respectively. BecauseP  .014 P  .035
of a relatively late onset of symptoms, we used five age-
adjusted penetrance classes. Phenocopy penetrance of
.001 was used throughout. For each marker, allele fre-
quencies were determined by an allele-counting method
using pedigree data themselves. To see whether misspeci-
fication of allele frequencies had an effect on the ob-
tained results, LOD-score analysis for the high-density
markers on 4cen and 17q22-q24 was also performed
under the assumption of equal allele frequencies.
To test for linkage disequilibrium with each marker
locus of the high-density maps, the data were analyzed
by the method of Terwilliger (1995). Affected-sib-pair
analysis was performed by a LOD score–based algo-
rithm (Knapp et al. 1994; Kuokkanen et al. 1996).
Results
Our initial low- and high-resolution screens consisted
of 104 individuals in 16 pedigrees selected from 21 MS
families. Five of the 21 pedigrees were not included in
the genome scan, because of their small size. These five
families were included in the final phase of the study, in
which we genotyped a total of 191 individuals in 21
families for 34 high-resolution markers mapping to the
most interesting regions (2q, 4cen, 10q, 11tel, and 17q)
identified in the genome scan. For these markers, we
performed two-point linkage analysis to allow the in-
corporation of all available pedigree information in the
analysis.
For the initial low-resolution scan, we genotyped 328
polymorphic markers at an average spacing of 12 cM.
The information content for the genome scan averaged
60%.Multipoint, nonparametric linkage analysis for the
low-resolution genome scan was performed by use of
two data sets: all pedigrees ( ) and a subset ofn  16
pedigrees from the Vaasa region ( ). The lattern  11
data set is composed of families from a high-risk area
in western Finland (Wikstro¨m 1975; Kinnunen et al.
1983). In both cases, the initial genome screen revealed
no statistically significant ( ; )5P ! 2# 10 NPL 1 4.1all
or suggestive evidence ( ; ) for3P ! 1# 10 NPL 1 3.0all
susceptibility loci predisposing toMS (Lander and Krug-
lyak 1995). However, we observed slightly positive NPL
scores in several regions (fig. 2). Ten chromosomal ar-
eas—on 2q, 3q, 4cen, 5p, 6p, 10q, 11tel, 17q, 18tel,
and 19tel—were identified as having (NPL 1 1 P !all
), the criterion that we had set for further exami-.16
nation. The regions with on chromosomes 5NPL 1 1all
and 6 did not require follow-up, since we previously had
published our findings from the high-resolutionmapping
of 5p14-p12 and of the HLA complex on chromosome
6 in the same MS families (Tienari et al. 1993; Kuok-
kanen et al. 1996). Accordingly, high-resolution map-
ping was focused on the other regions with NPL 1 1all
(2q, 3q, 4cen, 10q, 11tel, 17q, 18tel, and 19tel). In each
region, additional markers were genotyped and analyzed
separately for all MS families and for Vaasa families, by
multipoint, nonparametric linkage analysis. In all
regions, genotyping of additional markers increased the
information content to 170%, which we considered ad-
equate for the present purpose.
The NPL scores from the high-resolution screen of 16
pedigrees are illustrated, as solid red lines, in figure 2.
In three chromosomal regions an increase of the maxi-
mum NPL score was obtained: on 4cen the NPL score
increased from ( ) toNPL  1.17 P  .12 NPL all all
( ), on 11tel from ( )2.23 P  .02 NPL  1.02 P  .15all
to ( ), and on 17q22-q24 fromNPL  2.0 P  .03all
( ) to ( ). TheNPL  1.33 P  .1 NPL  2.34 P  .01all all
NPL score for markers on 2q23 and 10q21 did not
change; and for markers on 3q, 18tel, and 19tel the NPL
score declined. No evidence for linkage disequilibrium
was observed with any of the marker loci of the denser
marker maps.
Since, even with the high-resolution map, we did not
find suggestive evidence of linkage to any locus, we ex-
tended our analysis to all individuals from the 21 mul-
tiplex MS families, on the peak chromosomal areas on
2q32, 4cen, 10q21, 11cen, and 17q22-q24. In these
regions, we genotyped the markers of our high-resolu-
tion map with 191 DNAs and performed two-point link-
age analysis, using four different modes of inheritance
(see Families, Material, and Methods section). Detailed
LOD-score results for the high-resolution markers are
available from our Website at http://www.ktl.fi/molbia/
ms. As before, pairwise linkage analysis was performed
separately for the complete pedigree material and for the
Vaasa pedigrees.
Chromosomes 2 and 10
In the regions of 2q32 and 10q21, the LOD-score
results were not impressive for either chromosomal site:
near D2S1391 the maximum LOD score (Zmax) was 0.73
( ; dominant model, ), and near D10S1220v  .22 f  .76
Zmax was 0.95 ( ; dominant model, ).v  .06 f  .05
Figure 2 NPLall statistic (thicker line[y1-axis]) and information content (thinner line[y2-axis]) for each chromosome analyzed in the genome scan of 16 families genotyped with 328 low-resolution
markers (x-axis). The red line represents the NPLall statistic produced from the analysis of 16 families for low-resolution markers plus 40 additional high-resolution markers (indicated by vertical red
ticks on the x-axis). The names (in map-position order) of the added high-resolution markers are as follows: chromosome 2—D2S2188, D2S148, D2S389, D2S2318, D2S155, andD2S2321; chromosome
3—D3S3576, D3S1589, D3S1290, D3S3554, D3S3694, and D3S1550; chromosome 4—D4S3244, D4S2408, D4S2629, D4S3254, D4S2379, D4S2432, and D4S2393; chromosome 10—D10S196,
D10S1790, D10S1652, and D10S1672; chromosome 11—D11S910, D11S969, and D11S968; chromosome 17—D17S787, D17S794, D17S807, D17S1882, D17S795, D17S2059, and D17S949;
chromosome 18—D18S54, D18S52, and D18S62; and chromosome 19—APOC2, D19S867, D19S907, and D19S206.
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Chromosome 4
For chromosome 4 markers we did not detect sug-
gestive evidence of linkage in two-point LOD-score anal-
ysis (fig. 3). The Zmax was obtained with GATA28F03
( , ) under a dominant model withZ  0.96 v  .16max
low penetrance ( ). For the Vaasa pedigrees thef  .05
Zmax of 1.35 ( ; dominant model, ) wasv  .08 f  .05
detected with GATA28F03. The magnitude of the LOD
scores remained similar in two-point linkage analysis
when equal allele frequencies were applied to the mark-
ers (data not shown). Affected-sib-pair analysis with
GATA28F03 showed increased allele sharing IBD, both
for all pedigrees ( ) and for Vaasa pedigreesP  .005
( ). No evidence for locus heterogeneity couldP  .0005
be detected.
Chromosome 11
For 11qter, two-point LOD score analysis provided
( ), with D11S910, under a recessiveZ  1.1 v  .12max
model with low penetrance ( ). Two other, moref  .05
telomeric markers, D11S969 and D11S968, also pro-
duced slightly positive LOD scores—0.8 and 0.7, re-
spectively. Additionally, increased allele sharing among
affected sib pairs was detected with D11S910 (P 
), with D11S969 ( ), and with D11S968.001 P  .008
( ).P  .008
Chromosome 17
The results of two-point LOD-score analysis for the
high-resolution markers on 17q22-q24 are shown in fig-
ure 3. We show only the LOD-score results for a dom-
inant model with low penetrance ( ), since thisf  .05
mode of inheritance systematically revealed the highest
LOD scores. Linkage analysis with all pedigrees yielded
a two-point Zmax of 2.8 ( ) with D17S807, pro-v  .04
viding suggestive evidence for linkage. A few adjacent
markers, both proximal and distal to D17S807, also
produced positive LOD scores. Similarly, in the panel of
the Vaasa pedigrees, two-point–LOD-score linkage anal-
ysis provided a Zmax of 3.5 ( ) at D17S807, withv  .0
flanking markers also providing suggestive LOD scores.
As expected, a small increase in two-point LOD scores
occurred for all markers on 17q22-q24 when equal allele
frequencies were applied to markers. For D17S807, the
LOD score increased from 2.8 to 3.6 in the complete
pedigree material and from 3.5 to 4.2 in the subset of
pedigrees from Vaasa. This would further indicate that
our result at the D17S807 locus could not have been
dramatically influenced by incorrect allele-frequency es-
timates. Evidence for locus heterogeneity could not be
detected, and allelic association was not found, for any
of the markers on 17q22-q24.
Chromosome 19
The distal region of chromosome 19 is of particular
interest, since it harbors a gene coding for apolipoprotein
C-2 (APOC2). Some evidence for the role of this gene
in MS susceptibility has been reported in different pop-
ulations (Ebers et al. 1996; The Multiple Sclerosis Ge-
netics Group 1996; Sawcer et al. 1996). Although the
NPL scores decreased in our high-resolution multipoint
analysis, we analyzed the intragenic APOC2 marker in
21 MS pedigrees and performed two-point linkage anal-
ysis, using four different modes of inheritance. No evi-
dence of linkage or allelic association was observed.
Discussion
Given the evidence for genetic heterogeneity of MS,
we have focused the genetic studies ofMS on the isolated
Finnish population. To further minimize genetic heter-
ogeneity, a majority of our pedigrees were collected from
the high-risk region of Vaasa, in western Finland (Wik-
stro¨m 1975; Kinnunen et al. 1983). In the present study,
we have performed a genomewide scan for genes pre-
disposing to MS in the Finnish multiplex families. This
strategy aimed to systematically identify potential link-
ages for MS susceptibility, throughout the genome. The
results obtained by a two-stage mapping strategy of 354
markers suggest one additional vulnerability locus for
MS, on 17q22-q24, in our study material.
Multipoint, nonparametric linkage analysis of the
low- and high-resolution screens in 16 pedigrees pro-
vided hints for the involvement of the chromosomal re-
gion 17q22-q24.When all individuals from the complete
family material ( ) were included, severalmarkersn  21
on 17q22-q24 produced positive two-point LOD scores
under the dominant model, with a maximum with
D17S807 ( , ). In the subset of VaasaZ  2.8 v  .04max
pedigrees, the pairwise Zmax for D17S807 was even
higher ( , ), indicating that the role ofZ  3.5 v  .0max
this putative susceptibility locus may be more pro-
nounced in the families originating from this subisolate
in western Finland.
One needs to be cautious when interpreting the link-
age results of markers on 17q22-q24, since none of the
loci meet the most stringent level of statistical signifi-
cance for linkage (Lander and Kruglyak 1995). How-
ever, it is of special interest that a recent genomewide
scan of MS in British families also showed evidence for
linkage on 17q22-q24 ( ), with exactly theP  .0004
same markers (D17S807 and D17S795) where our
strongest results occur (Sawcer et al. 1996).
It is highly encouraging that, in a relatively small num-
ber of families originating from a population subisolate,
perhaps representing a rare familiar form of MS, it is
Kuokkanen et al.: Genome Scan of MS in Finnish Families 1385
Figure 3 Two-point Zmax values of the high-resolution markers on chromosome 4cen and 17q22-q24, obtained by use of MLINK,
FASTLINK version 2.2. In both panel A (4cen) and panel B (17q22-q24), the upper part of the diagram demonstrates Zmax for 21 Finnish
families, and the lower part of the diagram shows the results for 14 families from the province of Vaasa. Zmax values are shown on the vertical
axis. The horizontal axis shows marker names and the sex-average distances between the adjacent markers (in centimorgans [cM]). The
chromosome 4 map was obtained from CHLC (version 6.0), and the chromosome 17 map was obtained from Marshfield Medical Research
Center integrated marker maps. All Zmax scores were calculated under a dominant mode of inheritance with low penetrance ( ).P  .05
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possible to identify suggestive linkage to the same chro-
mosomal region where it also was detected in an inde-
pendent genomewide screen in a more mixed population
(Sawcer et al. 1996). This may suggest that data from
families from genetic isolates not only reveal rare loci
that do not contribute to genetic susceptibility in other
populations but can aid in the identification of loci that
have a more general impact.
Allelic association could not be detected with any
markers on 17q22-q24, in either the present study or
the British study. One explanation may be that the mark-
ers are still too distant from the susceptibility gene itself
or alternatively, that, even in the Finnish genetic iso-
late, there may be multiple ancestral predisposing alleles
for this relatively common disease. In the future, the
finding of allelic association either in the Finnish pop-
ulation or in the Vaasa subpopulation would greatly
facilitate the cloning of this putative susceptibility gene
on 17q22-q24.
In addition to the suggestive evidence that we have
presented here for linkage to 17q22-q24, our previous
studies, based on a candidate-gene approach in the same
MS families, have provided both statistically significant
evidence of linkage of MS to the HLA complex and
suggestive evidence of linkage of MS to the Golli-MBP
gene (Tienari et al. 1992b, 1993). The role of MBP in
MS may be either of minor effect or population specific,
since this candidate gene has not shown positive evidence
of linkage or association in several other populations
(Rose et al. 1993; Eoli et al. 1994; Vandervyer et al.
1994; Wood et al. 1994). Furthermore, we have found
suggestive evidence for linkage to a locus on 5p14-p12
by performing screening of human chromosomal regions
syntenic to the susceptibility loci of murine EAE (Sund-
vall et al. 1995; Kuokkanen et al. 1996). Interestingly,
a genomewide scan in Canadian families also has pro-
vided suggestive evidence for linkage between MS and
markers on the proximal limit of 5p14-p12 (Ebers et al.
1996). Thus, one of the genes predisposing to MS may
represent a homologue of Eae2.
In the present study, the regions 5p14-p12 and 6p21
met our criterion for follow-up in the initial, low-reso-
lution genome scan. By contrast, chromosome 18qter
did not reveal any hint of linkage in the genome scan,
most likely because of the fact that the markers on
18q22-q23 were not located close enough to the MBP
locus. The other sites chosen for follow-up in the present
study were not consistent with any regions of interest
detected in previously published genomewide searches
for MS linkage.
The finding of evidence for linkage of multiple loci in
the same limited set of MS families can be explained by
a selection bias: we have selected exceptional MS fam-
ilies with multiple affected cases. In such families, en-
richment of several predisposing genes is highly possible,
especially since most of the families originate from a
subisolate from western Finland.
In summary, a genomewide scan was performed in
Finnish multiplex MS families. In addition to the loci
identified by us before, evidence suggestive of a novel
predisposing locus was found in the chromosomal region
of 17q22-q24. The same region recently has been im-
plicated as showing a highly suggestive linkage to MS,
by a genomewide scan in British families. Thus, our pos-
itive results provide further support for this region’s con-
tribution to MS susceptibility.
Acknowledgments
We thank Anne Wikman, Linda Cutone, and Rose Kou-
yomjian for excellent technical assistance, and we thank An-
drew Kirby for writing the program for presenting the genome-
scan statistics. Above all, we wish to thank the participating
Finnish MS families. This work was financially supported in
part by National Institute of Health grant HG00098 (to E.S.L),
by support from the Academy of Finland and European Com-
mission contract BMH4-CT97-2522 (both to L.P.), and by
grants from the Cultural Foundation of Finland, the Maud
Kuistilas’s Foundation, the FinnishMedical Society Duodecim,
The Farmos and Orion Research Foundation, and theMultiple
Sclerosis Foundation of Finland (all to S.K.). J.D.T. is a Hitch-
ings-Elion Fellow (Burroughs-Wellcome Foundation).
References
Beall SS, Concannon P, Charmley P, McFarland HF, Gatti RA,
Hood LE, McFarlin DE, et al (1989) The germline repertoire
of T cell receptor b-chain genes in patients with chronic
progressive multiple sclerosis. J Neuroimmunol 21:59–66
Cottingham RW Jr, Idury RM, Scha¨ffer AA (1993) Faster se-
quential genetic linkage computations. Am J HumGenet 53:
252–263
de la Chapelle A (1993) Disease gene mapping in isolated
human populations: the example of Finland. J Med Genet
30:857–865
Dib C, Faure´ S, Fizames C, Samson D, Drouot N, Vignal A,
Millasseau P, et al (1996) A comprehensive genetic map of
the human genome based on 5264 microsatellites. Nature
380:152–154
Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S,
HarderW,Murray TJ, et al (1986) A population-based study
of multiple sclerosis in twins. N Engl J Med 315:1638–1642
Ebers GC, Cousin HK, Feasby TE, Paty DW (1981) Optic
neuritis in familial MS. Neurology 31:1138–1142
Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, An-
derson C, Armstrong H, et al (1996) A full genome search
in multiple sclerosis. Nat Genet 13:472–476
Ebers GC, Sadovnick AD, Risch NJ, the Canadian Collabo-
rative Study Group (1995) A genetic basis for familial ag-
gregation in multiple sclerosis. Nature 377:150–151
Eoli M, Pandolfo M, Milanese C, Gasparini P, Salmaggi A,
Zeviani M (1994) The myelin basic protein gene is not a
Kuokkanen et al.: Genome Scan of MS in Finnish Families 1387
major susceptibility locus for multiple sclerosis in Italian
patients. J Neurol 241:615–619
Hillert J, Chunmao L, Olerup O (1991) No association with
germline T cell receptor b-chain gene alleles or haplotypes
in Swedish patients with multiple sclerosis. J Neuroimmunol
31:141–147
Kinnunen E, Wikstro¨m J, Porras J, Palo J (1983) The epide-
miology of multiple sclerosis in Finland: increase of prev-
alence and stability of foci in high-risk areas. Acta Neurol
Scan 67:255–262
Knapp M, Seuchter SA, Baur MP (1994) Linkage analysis in
nuclear families. II. Relationship between affected sib-pair
test and lod score analysis. Hum Hered 44:44–51
Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996) Par-
ametric and nonparametric linkage analysis: a unified mul-
tipoint approach. Am J Hum Genet 58:1347–1363
Kuokkanen S, Sundvall M, Terwilliger JD, Tienari PJ, Wik-
stro¨m J, Holmdahl R, Pettersson U, et al (1996) A putative
vulnerability locus to multiple sclerosis maps to 5p14-p12
in a region syntenic to the murine locus Eae2. Nat Genet
13:477–480
Lander E, Kruglyak L (1995) Genetic dissection of complex
traits: guidelines for interpreting and reporting linkage re-
sults. Nat Genet 11:241–247
Lathrop GM, Lalouel JM, Julier CA, Ott J (1984) Strategies
for multilocus linkage analysis in humans. Proc Natl Acad
Sci USA 81:3443–3446
Lynch SG, Rose JW, Petajan JH, Stauffer D, Kamerath C, Lep-
pert M (1991) Discordance of T-cell receptor-chain genes in
familial multiple sclerosis. Ann Neurol 30:402–410
Multiple Sclerosis Genetics Group, The (1996) A complete
genomic screen for multiple sclerosis underscores a role for
the major histocompatibility complex. Nat Genet 13:
469–471
Murray JC, Buetow KH, Weber JL, Ludwigsen S, Scherpbier-
Heddema T, Manion F, Quillen J, et al (1994) A compre-
hensive human linkage map with centimorgan density: Co-
operative Human Linkage Center (CHLC). Science 265:
2049–2054
Olerup O, Hillert J (1991) HLA class II–associated genetic
susceptibility in multiple sclerosis: a critical evaluation. Tis-
sue Antigens 38:1–15
Ott J (ed) (1991) Analysis of human genetic linkage. Johns
Hopkins University Press, Baltimore, London
Poser CM, Paty DW, Scheinberg L (1983) New diagnostic
criteria for multiple sclerosis: guidelines for research pro-
tocols. Ann Neurol 13:227–231
Rose J, Gerken S, Lynch S, Pisani P, Varvil T, Otterud B, Lep-
pert M (1993) Genetic susceptibility in familial multiple scle-
rosis not linked to the myelin basic protein gene. Lancet
341:1179–1181
Sadovnick AD, Baird PA, Ward RH (1988) Multiple sclerosis:
updated risks for relatives. Am J Med Genet 29:533–541
Sadovnick AD, Ebers GC, Dyment DA, Risch NJ, the Cana-
dian Collaborative Study Group (1996) Evidence for genetic
basis of multiple sclerosis. Lancet 347:1728–1730
Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway
J, Robertson N, et al (1996) A genome screen in multiple
sclerosis reveals susceptibility loci on chromosome 6p21 and
17q22. Nat Genet 13:464–468
Scha¨ffer AA, Gupta SK, Shriram K, Cottingham RW (1994)
Avoiding recomputation in linkage analysis. HumHered 44:
225–237
Seboun E, Robinson MA, Doolittle TH, Ciulla TA, Kindt TJ,
Hauser SL (1989) A susceptibility locus for multiple sclerosis
is linked to the T cell receptor b chain complex. Cell 57:
1095–1100
Sundvall M, Jirholt J, Yang H-T, Jansson L, Engstro¨m A˚, Pet-
tersson U, Holmdahl R (1995) Identification of murine loci
associated with susceptibility to chronic experimental au-
toimmune encephalomyelitis. Nat Genet 10:313–317
Terwilliger JD (1995) A powerful likelihood method for the
analysis of linkage disequilibrium between trait loci and one
or more polymorphic marker loci. Am J Hum Genet 56:
777–787
Tienari PJ, Salonen O, Wikstro¨m J, Valanne L, Palo J (1992a)
Familial multiple sclerosis: MRI findings in clinically af-
fected and unaffected siblings. J Neurol Neurosurg Psychi-
atry 55:883–886
Tienari PJ, Wikstro¨m J, Koskimies S, Partanen J, Palo J, Pel-
tonen L (1993) Reappraisal of HLA in multiple sclerosis:
close linkage in multiplex families. Eur J Hum Genet 1:
257–268
Tienari PJ, Wikstro¨m J, Sajantila A, Palo J, Peltonen L (1992b)
Genetic susceptibility to multiple sclerosis linked to myelin
basic protein gene. Lancet 340:987–991
Vandervyer C, Stinissen P, Cassiman J-J, Raus J (1994) Myelin
basic protein gene polymorphism is not associated with
chronic progressive multiple sclerosis. J Neuroimmunol 52:
97–99
Wikstro¨m J (1975) Studies on the clustering of multiple scle-
rosis in Finland. II. Microepidemiology in one high-risk
county with special reference to familial cases. Acta Neurol
Scand 51:173–183
Wood NW, Holmans P, Clayton D, Robertson N, Compston
DAS (1994) No linkage or association betweenmultiple scle-
rosis and the myelin basic protein gene in affected sibling
pairs. J Neurol Neurosurg Psychiatry 57:1191–1194
